Nucor (NUE) Competitors

In the previous week, Nucor had 16 more articles in the media than ATI. MarketBeat recorded 27 mentions for Nucor and 11 mentions for ATI. Nucor's average media sentiment score of 0.84 beat ATI's score of 0.69 indicating that Nucor is being referred to more favorably in the media.

Nucor presently has a consensus target price of $243.80, suggesting a potential upside of 6.40%. ATI has a consensus target price of $164.38, suggesting a potential upside of 3.57%. Given Nucor's higher probable upside, equities research analysts plainly believe Nucor is more favorable than ATI.

76.5% of Nucor shares are owned by institutional investors. 0.6% of Nucor shares are owned by company insiders. Comparatively, 1.0% of ATI shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Nucor has higher revenue and earnings than ATI. Nucor is trading at a lower price-to-earnings ratio than ATI, indicating that it is currently the more affordable of the two stocks.

ATI has a net margin of 9.26% compared to Nucor's net margin of 6.82%. ATI's return on equity of 26.44% beat Nucor's return on equity.

Nucor has a beta of 1.87, suggesting that its stock price is 87% more volatile than the broader market. Comparatively, ATI has a beta of 0.94, suggesting that its stock price is 6% less volatile than the broader market.

Cabot has a net margin of 7.97% compared to Nucor's net margin of 6.82%. Cabot's return on equity of 21.33% beat Nucor's return on equity.

In the previous week, Nucor had 4 more articles in the media than Cabot. MarketBeat recorded 27 mentions for Nucor and 23 mentions for Cabot. Cabot's average media sentiment score of 0.85 beat Nucor's score of 0.84 indicating that Cabot is being referred to more favorably in the media.

Cabot pays an annual dividend of $1.80 per share and has a dividend yield of 2.1%. Nucor pays an annual dividend of $2.24 per share and has a dividend yield of 1.0%. Cabot pays out 34.0% of its earnings in the form of a dividend. Nucor pays out 22.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cabot has raised its dividend for 14 consecutive years and Nucor has raised its dividend for 52 consecutive years.

Cabot currently has a consensus target price of $76.25, suggesting a potential downside of 8.95%. Nucor has a consensus target price of $243.80, suggesting a potential upside of 6.40%. Given Nucor's stronger consensus rating and higher probable upside, analysts plainly believe Nucor is more favorable than Cabot.

Nucor has higher revenue and earnings than Cabot. Cabot is trading at a lower price-to-earnings ratio than Nucor, indicating that it is currently the more affordable of the two stocks.

93.2% of Cabot shares are held by institutional investors. Comparatively, 76.5% of Nucor shares are held by institutional investors. 3.1% of Cabot shares are held by company insiders. Comparatively, 0.6% of Nucor shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Cabot has a beta of 0.78, meaning that its stock price is 22% less volatile than the broader market. Comparatively, Nucor has a beta of 1.87, meaning that its stock price is 87% more volatile than the broader market.

Nucor has a net margin of 6.82% compared to Chemours' net margin of -6.82%. Chemours' return on equity of 52.49% beat Nucor's return on equity.

In the previous week, Nucor had 6 more articles in the media than Chemours. MarketBeat recorded 27 mentions for Nucor and 21 mentions for Chemours. Nucor's average media sentiment score of 0.84 beat Chemours' score of 0.54 indicating that Nucor is being referred to more favorably in the news media.

Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 1.4%. Nucor pays an annual dividend of $2.24 per share and has a dividend yield of 1.0%. Chemours pays out -13.3% of its earnings in the form of a dividend. Nucor pays out 22.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Nucor has raised its dividend for 52 consecutive years. Chemours is clearly the better dividend stock, given its higher yield and lower payout ratio.

Chemours currently has a consensus target price of $22.40, indicating a potential downside of 9.99%. Nucor has a consensus target price of $243.80, indicating a potential upside of 6.40%. Given Nucor's stronger consensus rating and higher possible upside, analysts plainly believe Nucor is more favorable than Chemours.

Nucor has higher revenue and earnings than Chemours. Chemours is trading at a lower price-to-earnings ratio than Nucor, indicating that it is currently the more affordable of the two stocks.

76.3% of Chemours shares are owned by institutional investors. Comparatively, 76.5% of Nucor shares are owned by institutional investors. 0.9% of Chemours shares are owned by company insiders. Comparatively, 0.6% of Nucor shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Chemours has a beta of 1.47, meaning that its stock price is 47% more volatile than the broader market. Comparatively, Nucor has a beta of 1.87, meaning that its stock price is 87% more volatile than the broader market.

Nucor has a beta of 1.87, indicating that its stock price is 87% more volatile than the broader market. Comparatively, Celanese has a beta of 0.81, indicating that its stock price is 19% less volatile than the broader market.

In the previous week, Celanese had 9 more articles in the media than Nucor. MarketBeat recorded 36 mentions for Celanese and 27 mentions for Nucor. Nucor's average media sentiment score of 0.84 beat Celanese's score of 0.24 indicating that Nucor is being referred to more favorably in the media.

Nucor has a net margin of 6.82% compared to Celanese's net margin of -11.54%. Nucor's return on equity of 10.68% beat Celanese's return on equity.

Nucor pays an annual dividend of $2.24 per share and has a dividend yield of 1.0%. Celanese pays an annual dividend of $0.12 per share and has a dividend yield of 0.2%. Nucor pays out 22.2% of its earnings in the form of a dividend. Celanese pays out -1.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Nucor has raised its dividend for 52 consecutive years. Nucor is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

76.5% of Nucor shares are owned by institutional investors. Comparatively, 98.9% of Celanese shares are owned by institutional investors. 0.6% of Nucor shares are owned by insiders. Comparatively, 0.3% of Celanese shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Nucor has higher revenue and earnings than Celanese. Celanese is trading at a lower price-to-earnings ratio than Nucor, indicating that it is currently the more affordable of the two stocks.

Nucor currently has a consensus target price of $243.80, indicating a potential upside of 6.40%. Celanese has a consensus target price of $67.47, indicating a potential upside of 12.70%. Given Celanese's higher probable upside, analysts plainly believe Celanese is more favorable than Nucor.